Barry G. Caldwell joins Iridex Corp. as president and chief executive officer and as a member of the board of directors. He succeeds Theodore A. Boutacoff, who has been elected chairman of the board for Iridex.
Caldwell worked for Alcon Laboratories for more than 2 decades in numerous executive positions, including vice president of Alcon Canada as well as vice president and general manager of Alcon’s U.S. Surgical Division.
“His successful track record includes achievements in operating performance, strategic planning, mergers and acquisitions, and executing strategic initiatives-which resulted in profitable revenue growth,” Boutacoff said.
“With more than 30 years of experience in the ophthalmic sector and more than 20 years of tenure at Alcon, Barry has well-established relationships with physicians, industry executives, and key regulatory and legislative opinion leaders that will be beneficial to Iridex,” Boutacoff added.